Nicholas Company’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
213,220
+105
+0% +$2.44K 0.08% 174
2026
Q1
$5.74M Sell
213,115
-1,605
-0.7% -$52.1K 0.11% 161
2025
Q4
$6.84M Sell
214,720
-36,370
-14% -$1.07M 0.12% 151
2025
Q3
$6.97M Sell
251,090
-45
-0% -$1.3K 0.12% 152
2025
Q2
$8.16M Sell
251,135
-65
-0% -$2.1K 0.14% 138
2025
Q1
$8.78M Buy
251,200
+185
+0.1% +$5.81K 0.15% 131
2024
Q4
$5.82M Hold
251,015
0.09% 188
2024
Q3
$7.86M Buy
251,015
+17,015
+7% +$522K 0.13% 152
2024
Q2
$6.48M Buy
234,000
+15,320
+7% +$457K 0.11% 171
2024
Q1
$7.33M Buy
218,680
+14,990
+7% +$485K 0.12% 163
2023
Q4
$6.86M Buy
203,690
+21,690
+12% +$667K 0.12% 165
2023
Q3
$5.89M Buy
182,000
+29,485
+19% +$994K 0.12% 172
2023
Q2
$4.96M Buy
152,515
+56,915
+60% +$1.72M 0.09% 195
2023
Q1
$3.04M Buy
+95,600
New +$2.86M 0.06% 209

Other funds holding OPCH

Nicholas Company's OPCH Position: Q2 2026 in Review

Nicholas Company increased its Option Care Health (OPCH) stake by 0.05% in Q2 2026, buying an estimated $2.44K and bringing the position to 213,220 shares worth $4.47M. The position accounts for 0.08% of the portfolio, ranked #174.

Nicholas Company first reported a position in OPCH in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.78M in Q1 2025. 371 funds tracked by Wall St. Rank hold OPCH as of Q2 2026.

  • Nicholas Company held 213,220 shares of Option Care Health worth $4.47M as of Q2 2026.
  • Nicholas Company bought 105 Option Care Health shares in Q2 2026, an estimated $2.44K.
  • Option Care Health made up 0.08% of Nicholas Company's portfolio in Q2 2026, its #174 holding.
  • Nicholas Company first reported a position in Option Care Health in Q1 2023 and has held it in 14 quarters since.
  • Nicholas Company's Option Care Health position peaked at $8.78M in Q1 2025.
  • 371 funds tracked by Wall St. Rank held Option Care Health as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.